// App-Quantinova.ai

: Dynamic Changes in International Staging System As a Predictor of Survival Outcome in Patients with Advanced Multiple Myeloma

Researchers

Presenter

  • Jin-Liern Hong

Principal Investigators

  • Victoria Crossland

  • Aaron Galaznik

  • Paul Dolin

Medical Centers

  • Takeda Pharmaceuticals International Co., Cambridge, MA

  • Epidemiology, Takeda Pharmaceuticals International Co., London, United Kingdom

  • Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Deerfield, IL

Locations

  • United States

  • United Kingdom

Companies

  • Millennium Pharmaceu

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • beta-2 microglobulin

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved